Concomitant Epicardial Pulmonary Vein Isolation in Patients With Atrial Fibrillation Undergoing Elective Cardiac Surgery
Launched by MEDISCH SPECTRUM TWENTE · May 25, 2011
Trial Information
Current as of August 21, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥ 18 years of age
- • EHRA class ≤ 2
- • Documented history of paroxysmal, persistent, longstanding persistent or newly-diagnosed AF prior to admittance for cardiac surgery
- • Patients will have elective coronary surgery planned Able of providing informed consent
- Exclusion Criteria:
- • Patients ≥70 years of age
- • Pregnancy Patients with contraindications for oral anticoagulant agents
- • Patients undergoing emergency operation
- • Patients undergoing concomitant valve replacement
- • Severely enlarged LA (\>50 mm) on echocardiography
- • Prior AF ablation or AF surgery
About Medisch Spectrum Twente
Medisch Spectrum Twente (MST) is a leading healthcare institution located in the Netherlands, dedicated to providing high-quality medical care and advancing clinical research. As a regional hospital, MST is committed to improving patient outcomes through innovative treatment options and comprehensive clinical trials. The institution fosters collaboration among multidisciplinary teams of healthcare professionals, researchers, and academic partners, ensuring a robust environment for conducting research that adheres to the highest ethical standards. MST's focus on patient-centered care and its strategic initiatives in clinical research contribute significantly to the advancement of medical knowledge and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Enschede, Overijssel, Netherlands
Patients applied
Trial Officials
Marcoen Scholten, MD PhD
Principal Investigator
Medisch Spectrum Twente
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials